Title:
【発明の名称】シクロヘキサン誘導体及び治療薬としてのその使用
Document Type and Number:
Japanese Patent JP2003533519
Kind Code:
A
Abstract:
The present invention relates compounds of the formula (I): wherein ring A is a phenyl or pyridyl ring; X represents a linker selected from the group consisting of: (a), (b), (c), (d), (e), (f), (g), (h), (i), (j), (k), (l) and R1, R2, R3, R4, R5, R6, R7, R13, R14, R15, R16, R?17, R18, R19, R21a and R21b are as defined herein. The compounds are of particular use in the treatment or prevention of depression, anxiety, pain, inflammation, migraine, emesis or postherpetic neuralgia.
More Like This:
Inventors:
Castro Pinero, Jose Lewis
Kevin
Elliott, The Eason Machine
Holingworth, Gregory Jiyoung
Sail, Duncan Edward
Swain, Christopher Jiyoung
Yang, Lifou
Kevin
Elliott, The Eason Machine
Holingworth, Gregory Jiyoung
Sail, Duncan Edward
Swain, Christopher Jiyoung
Yang, Lifou
Application Number:
JP2001584262A
Publication Date:
November 11, 2003
Filing Date:
May 16, 2001
Export Citation:
Assignee:
Merck Sharp End Dome Limited
Merck End-Campany Inc.
Merck End-Campany Inc.
International Classes:
A61K31/075; A61K31/12; A61K31/135; A61K31/16; A61K31/165; A61K31/215; A61K31/341; A61K31/357; A61K31/40; A61K31/403; A61K31/41; A61K31/4164; A61K31/4196; A61K31/4355; A61K31/4402; A61K31/4406; A61K31/4409; A61K31/4453; A61K31/451; A61K31/472; A61K31/495; A61K31/496; A61K31/5375; A61K31/54; A61K31/55; A61P1/08; A61P25/04; A61P25/06; A61P25/22; A61P25/24; A61P29/00; A61P43/00; C07C43/178; C07C45/29; C07C49/497; C07C49/517; C07C49/697; C07C49/747; C07C49/753; C07C69/757; C07C69/767; C07C217/48; C07C217/52; C07C229/22; C07C233/23; C07C233/31; C07C233/32; C07C233/58; C07C233/59; C07C235/40; C07C235/80; C07C235/82; C07C237/04; C07C237/08; C07C237/24; C07D207/06; C07D207/16; C07D211/14; C07D211/18; C07D211/22; C07D211/38; C07D211/42; C07D211/46; C07D211/48; C07D211/58; C07D211/62; C07D211/70; C07D211/74; C07D213/38; C07D217/04; C07D233/90; C07D241/08; C07D257/04; C07D265/30; C07D275/04; C07D277/28; C07D295/04; C07D295/08; C07D295/096; C07D295/14; C07D295/15; C07D295/155; C07D295/185; C07D295/192; C07D295/205; C07D307/52; C07D317/72; C07D333/20; C07D401/04; C07D401/06; C07D413/04; C07D417/12; C07D487/08; C07D491/20; (IPC1-7): C07C43/178; A61K31/075; A61K31/12; A61K31/135; A61K31/16; A61K31/165; A61K31/215; A61K31/341; A61K31/357; A61K31/40; A61K31/403; A61K31/41; A61K31/4164; A61K31/4196; A61K31/4355; A61K31/4402; A61K31/4406; A61K31/4409; A61K31/4453; A61K31/451; A61K31/472; A61K31/495; A61K31/496; A61K31/5375; A61K31/54; A61K31/55; A61P1/08; A61P25/04; A61P25/06; A61P25/22; A61P25/24; A61P29/00; A61P43/00; C07C49/497; C07C49/517; C07C69/757; C07C69/767; C07C217/48; C07C217/52; C07C229/22; C07C233/32; C07C235/80; C07C237/08; C07C237/24; C07D207/06; C07D207/16; C07D211/14; C07D211/18; C07D211/22; C07D211/38; C07D211/42; C07D211/46; C07D211/48; C07D211/58; C07D211/62; C07D211/70; C07D211/74; C07D213/38; C07D217/04; C07D233/90; C07D241/08; C07D257/04; C07D265/30; C07D275/04; C07D277/28; C07D295/04; C07D295/08; C07D295/14; C07D307/52; C07D317/72; C07D333/20; C07D401/04; C07D413/04; C07D417/12; C07D487/08; C07D491/20
Attorney, Agent or Firm:
Yoshio Kawaguchi (4 outside)